Hetarylfuroxans: cytotoxic effect and induction of apoptosis in chronic myeloid leukemia K562 cells

被引:8
|
作者
Pukhov, S. A. [1 ]
Anikina, L. A. [1 ]
Larin, A. A. [2 ]
Fershtat, L. L. [2 ]
Kulikov, A. S. [2 ]
Makhova, N. N. [2 ]
机构
[1] Russian Acad Sci, Inst Physiol Act Cpds, 1 Severnyi Proezd, Chernogolovka 142432, Moscow Region, Russia
[2] Russian Acad Sci, ND Zelinsky Inst Organ Chem, 47 Leninsky Prosp, Moscow 119991, Russia
基金
俄罗斯基础研究基金会;
关键词
cytotoxicity; chronic myeloid leukemia K562; hetarylfuroxans; apoptosis; caspase-3; caspase-7; ANTIAGGREGANT ACTIVITY; TYROSINE KINASE; INHIBITORS; FUROXANS; SYSTEMS; EVENTS; DESIGN;
D O I
10.1007/s11172-019-2431-5
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Hetarylfuroxans (4-(2-methylpyridin-5-yloxy)-3-phenylfuroxan (1), bis(1,2,4-oxadiazol-3-yl)furoxan (2), and 4-amino-3-(indenotriazin-3-yl)furoxan (3)) exhibit in vitro cytotoxic activity against chronic myeloid leukemia K562 cells. All studied furoxans induce apoptosis in K562 cells. The experiments with activation of caspases-3 and -7 showed that furoxan 3 possessed the highest apoptosis-inducing capacity. The studied hetarylfuroxans were found to be the promising drug candidates for the treatment of chronic myeloid leukemia K562.
引用
收藏
页码:158 / 162
页数:5
相关论文
共 50 条
  • [31] Preparation of orpiment nanoparticles and their cytotoxic effect on cultured leukemia K562 cells
    Lin, Mei
    Wang, Ziyu
    Zhang, Dongsheng
    [J]. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2007, 7 (02) : 490 - 496
  • [32] Cytotoxic effect of trans-cinnamaldehyde on human leukemia K562 cells
    Jia-hua Zhang
    Li-qiong Liu
    Yan-li He
    Wei-jia Kong
    Shi-ang Huang
    [J]. Acta Pharmacologica Sinica, 2010, 31 : 861 - 866
  • [33] Induction of G2/M phase arrest by squamocin in chronic myeloid leukemia (K562) cells
    Lu, MC
    Yang, SH
    Hwang, SL
    Lu, YJ
    Lin, YH
    Wang, SR
    Wu, YC
    Lin, SR
    [J]. LIFE SCIENCES, 2006, 78 (20) : 2378 - 2383
  • [34] Activin A induction of erythroid differentiation sensitizes K562 chronic myeloid leukemia cells to a subtoxic concentration of imatinib
    Huang, Yu-Wen
    Lee, Wei-Hwa
    Tsai, Yu-Hui
    Huang, Huei-Mei
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2014, 306 (01): : C37 - C44
  • [35] Cytotoxic effect of trans-cinnamaldehyde on human leukemia K562 cells
    Zhang, Jia-hua
    Liu, Li-qiong
    He, Yan-li
    Kong, Wei-jia
    Huang, Shi-ang
    [J]. ACTA PHARMACOLOGICA SINICA, 2010, 31 (07) : 861 - 866
  • [36] Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells
    Zchong-Zcho Wu
    Ching-Ming Chien
    Sheng-Huei Yang
    Yi-Hsiung Lin
    Xiu-Wei Hu
    Yu-Jhang Lu
    Ming-Jung Wu
    Shinne-Ren Lin
    [J]. Molecular and Cellular Biochemistry, 2006, 292 : 99 - 105
  • [37] Induction of G2/M phase arrest and apoptosis by a novel enediyne derivative, THDA, in chronic myeloid leukemia (K562) cells
    Wu, Zchong-Zcho
    Chien, Ching-Ming
    Yang, Sheng-Huei
    Lin, Yi-Hsiung
    Hu, Xiu-Wei
    Lu, Yu-Jhang
    Wu, Ming-Jung
    Lin, Shinne-Ren
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2006, 292 (1-2) : 99 - 105
  • [38] Effect of Petiveria alliacea Extracts on Metabolism of K562 Myeloid Leukemia Cells
    Rojas, Laura
    Pardo-Rodriguez, Daniel
    Uruena, Claudia
    Lasso, Paola
    Arevalo, Cindy
    Cala, Monica P.
    Fiorentino, Susana
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (24)
  • [39] The Effect of Polyhydroxy Fullerene Derivative on Human Myeloid Leukemia K562 Cells
    Guo, Wei
    Liu, Xing
    Ye, Lianjie
    Liu, Jie
    Larwubah, Kollie
    Meng, Ge
    Shen, Weiqiang
    Ying, Xiangxian
    Zhu, Jun
    Yang, Shengjie
    Guo, Jianjun
    Jia, Yanrong
    Yu, Meilan
    [J]. MATERIALS, 2022, 15 (04)
  • [40] Induction of apoptosis and erythroid differentiation of human chronic myelogenous leukemia K562 cells by low concentrations of lidamycin
    Zhang, Chu
    Guo, Lu-Ying
    Mu, Dan
    Gong, Jian-Hua
    Chen, Jing
    [J]. ONCOLOGY REPORTS, 2019, 41 (01) : 475 - 482